Reading Time: 2 minutesIntroduction Post-stroke depression (PSD) is a common yet debilitating condition that affects a significant number of stroke survivors, particularly American males. This review aims to explore the efficacy of escitalopram, a selective serotonin reuptake inhibitor (SSRI), in managing PSD, highlighting its benefits and considerations for this specific demographic. Understanding Post-Stroke Depression Post-stroke depression is not merely a reaction to the life-altering effects of a stroke but a clinical condition that can impede recovery and quality of life. It is estimated that up to 33% of stroke survivors may experience PSD, with American males showing a higher prevalence due to factors … Continue reading
-
Injectable Sermorelin

-
Search -
Archives
- March 2026
- May 2025
- April 2025
- March 2025
- February 2025
- April 2024
- March 2024
- December 2023
- November 2023
- October 2023
- September 2023
- August 2023
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- February 2019
- January 2019
-
HGH Decline Charts

-
Sermorelin Products

-
Sermorelin Health











